can tirzepatide cause seizures (Zepbound) for weight loss Tirzepatide associated autoimmune encephalitis: A

They may include: nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation (burping), hypoglycemia in patients with diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis

This effect occurs through multiple pathways: decreased body weight reduces mechanical strain on arteries, GLP-1 signaling relaxes blood vessel walls, and the medication lowers inflammation markers linked to hypertension

Retatrutide has not been studied in lactating women, and the mechanism of action raises concerns about potential transfer to breast milk and effects on infant development

Standard dosing is 500mg two to three times daily with meals